FDA Approves NMN for Supplements, Opening Global Doors

The U.S. Food and Drug Administration (FDA) has given the green light for the use of β-Nicotinamide Mononucleotide (NMN) in dietary supplements. This approval comes after prolonged discussions and represents a pivotal advancement for the longevity sector.

With this decision, major e-commerce platforms, which had previously blocked NMN products, can now list them again, enhancing consumer access in a major market. Naturecan, a wellness brand championing science-driven innovation, views this as a crucial development for nutrition.

Paul Holmes from Naturecan emphasized the increased recognition of NMN as a reputable ingredient. This decision not only facilitates consumer choices but also invigorates global discussions on healthy aging and longevity nutrition.

The FDA's move highlights a stronger international focus on healthy aging research, reflecting the growing demand for innovative, safe supplements.